Renal Cancers Completed Phase 2 Trials for Aldesleukin (DB00041)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00853021Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the KidneyTreatment
NCT00085436DC Vaccine Combined With IL-2 and IFN╬▒-2a in Treating Patients With mRCCTreatment
NCT00003408Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With CancerTreatment
NCT00003091High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or MelanomaTreatment
NCT00002733Biological Therapy in Treating Patients With Metastatic CancerTreatment
NCT00031564Phase II Study of a B7-1 Gene-Modified Autologous Tumor Cell Vaccine and Systemic IL-2Treatment
NCT00100906Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell CancerTreatment